IL2 and neoplasm: Similarly, a delay in tumor growth may result from the combination of small-format IL-2 immunocytokines with high-affinity Nbs that target the tumor-specific Extra domain-B of fibronectin (EIIIB), which is present in the tumor extracellular matrix.